Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Germany’s Olaf Scholz dismisses fears over Deutsche Bank
    • Passport rift between UK and Spain leaves Gibraltar in limbo
    • Rahul Gandhi barred from India’s parliament following conviction over Modi remarks
    • ‘Trump without the nonsense’: DeSantis treads fine line as popularity ebbs
    • US charges crypto fugitive Do Kwon after Montenegro arrest
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Banks in turmoil
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • Executive pay at Silicon Valley Bank soared after big bet on riskier assets
      • Credit Suisse: the rise and fall of the bank that built modern Switzerland
      • Hindenburg Research shorts Jack Dorsey’s payments group Block
      • Swiss regulator defends $17bn wipeout of AT1 bonds in Credit Suisse deal
      • Credit funds scrutinise ‘mythical, enormous’ Silicon Valley Bank loan book
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • Deutsche Bank weighs on bank shares and global equities
      • Live news: Credit conditions ‘absolutely on the plate’ at next BoE decision, MPC’s Catherine Mann says
      • Germany’s Olaf Scholz dismisses fears over Deutsche Bank
      • Hindenburg Research shorts Jack Dorsey’s payments group Block
      • Swiss regulator defends $17bn wipeout of AT1 bonds in Credit Suisse deal
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
      Most Read
      • Conservatives win some culture battles, but they are losing the war
      • American banks face a looming credit risk
      • Credit Suisse’s fate casts a shadow over the European banking sector
      • Time to ask what the directors were doing at these failed banks
      • Yikes! What should I do with my mortgage?
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • Culture clash: the challenge of uniting fierce rivals UBS and Credit Suisse
      • From SVB to the BBC: why did no one see the crisis coming?
      • Social media content moderators lead charge for better rights
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • Is France on the road to a Sixth Republic?
      • Everything I, an Italian, thought I knew about Italian food is wrong
      • We should regulate SUVs out of existence
      • Journalist Bari Weiss: ‘I hate bullies, period’
      • To Istanbul, by train
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Johnson & Johnson Co Inc

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Tuesday, 7 February, 2023
      FT News Briefing podcast9 min listen
      The jig is up for the Texas two-step

      UK to design ‘digital pound’ that could fend off a future private tech rival

    • Monday, 6 February, 2023
      News in-depthBankruptcy
      Talc ruling a blow to J&J and the ‘Texas two-step’ bankruptcy jig

      Ruling by US court will make companies think twice about using Chapter 11 schemes to handle lawsuits

    • Tuesday, 31 January, 2023
      Lex
      J&J: court stops the music for the ‘Texas two-step’ Premium content

      Congress may eventually have to step in and create a new club to resolve mass torts

    • Monday, 30 January, 2023
      J&J blocked from using bankruptcy to resolve talcum powder lawsuits

      Ruling from US appeals court casts doubt on future of contentious ‘Texas two-step’ manoeuvre

    • Thursday, 5 January, 2023
      Lex
      J&J/Kenvue: IPO will test investor appetite Premium content

      A successful listing would focus J&J on its pharmaceutical and medical-device business

    • Tuesday, 1 November, 2022
      Lex
      J&J/Abiomed: healthcare giant pays high price to bulk up on medtech Premium content

      EV/ebitda multiple is rich, given the healthcare giant expects any potential cost savings to be ‘very modest’

    • Tuesday, 1 November, 2022
      Johnson & Johnson bucks global M&A slowdown with $16.6bn Abiomed deal

      Purchase of heart pumpmaker to help US pharma group focus on drugs and medical devices

    • Tuesday, 25 October, 2022
      The Big Read
      ‘Texas two-step’: the US legal move letting corporations off the hook

      Critics say the controversial legal manoeuvre allows companies to bypass their responsibilities. But judges are beginning to crack down

    • Monday, 22 August, 2022
      J&J tries to extend its ‘Texas two-step’ to halt two states’ talc cases

      New Mexico and Mississippi say consumer company’s strategy is making a ‘mockery’ of bankruptcy law

    • Tuesday, 19 July, 2022
      J&J blames US dollar strength for second outlook cut in as many quarters

      Pharmaceutical group issues downbeat forecast despite better than expected quarterly results

    • Tuesday, 21 June, 2022
      Behind the Money podcast28 min listen
      Inside Johnson & Johnson’s bankruptcy two-step

      This legal manoeuvre is setting a new precedent for corporations to evade accountability in America

    • Sunday, 6 March, 2022
      J&J targets Chinese biotech deals as western pharma groups look east

      US drugmaker seeks more tie-ups after existing collaboration yields new cancer treatment

    • Tuesday, 1 March, 2022
      LexBankruptcy
      US bankruptcy/J&J: new turn for Texas two-step Premium content

      Ruling opens a fresh chapter for resolving US tort cases

    • Monday, 28 February, 2022
      Health
      US lawmakers plan bill to outlaw ‘Texas two-step’ bankruptcy ploy

      Fight moves to Congress after judge allows J&J to use scheme to help it settle billions in legal claims

    • Friday, 25 February, 2022
      Johnson & Johnson can proceed with controversial bankruptcy strategy, judge rules

      Decision allows group to use the manoeuvre to manage tens of thousands of claims that its baby talc caused cancer

    • Monday, 14 February, 2022
      Legal services
      Architects of ‘Texas two-step’ lambast J&J for its use of the manoeuvre

      Lawyer who drafted statute says companies should not deploy it to ‘skirt’ their obligations

    • Thursday, 6 January, 2022
      Covid-19 vaccines
      Covid vaccine makers face investor pressure over global access

      Asset managers call for pharma executive pay to be linked to equitable distribution of jabs

    • Thursday, 30 December, 2021
      Covid-19 vaccines
      Johnson & Johnson booster slashes risk of Omicron hospitalisation, study shows

      Two doses cut likelihood by up to 85%, according to real-world South African research

    • Sunday, 12 December, 2021
      South Africa
      South Africa’s leader Cyril Ramaphosa tests positive for Covid

      Country tackles one of the first waves of infections caused by Omicron variant

    • Wednesday, 1 December, 2021
      ExplainerCovid-19 vaccines
      Will Covid vaccines have to be updated for Omicron?

      Drugmakers are stress-testing existing jabs while preparing new formulas

    • Monday, 29 November, 2021
      FT live news
      News updates from November 29: WHO warns of ‘very high’ risk from Omicron, Dorsey resigns as Twitter CEO, German inflation hits 6%
    • Friday, 19 November, 2021
      News in-depth
      Johnson & Johnson touts ‘golden moment’ to pursue pharma-led future

      Plan to spin off consumer division has failed to thrill investors

    • Monday, 15 November, 2021
      The FT ViewThe editorial board
      Conglomerates’ cycle of break-ups turns again

      Advisers benefit from multinationals’ current wave of spin-offs

    • Friday, 12 November, 2021
      Lex
      Johnson & Johnson: the break-up band-aid comes off Premium content

      A successful split of the consumer and pharma divisions would, on paper, unlock value

    • Friday, 12 November, 2021
      Johnson & Johnson to spin off consumer business

      World’s largest healthcare group follows trend to slim down with plans to focus on pharmaceuticals

    Previous page You are on page 1 Next page

    Be part of FT Community

    Discover unmissable flagship events and members only communities to expand your thinking and elevate your career

    FT Live
    US Pharma and Biotech Summit
    Leading Life Sciences into the Future
    Tuesday, 16th MayNew York, US & Online
    Learn more about FT Community

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsSecondary Schools

    Tools

    PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition

    Top sections

    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Banks in turmoil
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports

    FT recommends

    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • FTfm
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today's Newspaper (ePaper)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In